BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carbone F, Van den Houte K, Clevers E, Andrews CN, Papathanasopoulos A, Holvoet L, Van Oudenhove L, Caenepeel P, Arts J, Vanuytsel T, Tack J. Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study. Am J Gastroenterol. 2019;114:1265-1274. [PMID: 31295161 DOI: 10.14309/ajg.0000000000000304] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 31.5] [Reference Citation Analysis]
Number Citing Articles
1 Ehrenpreis ED, Kruchko DH. Editorial: tradipitant has promise for treating gastroparesis but leaves gastric function alone. Aliment Pharmacol Ther 2022;56:540-1. [PMID: 35804474 DOI: 10.1111/apt.17090] [Reference Citation Analysis]
2 Black CJ, Paine PA, Agrawal A, Aziz I, Eugenicos MP, Houghton LA, Hungin P, Overshott R, Vasant DH, Rudd S, Winning RC, Corsetti M, Ford AC. British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut 2022:gutjnl-2022-327737. [PMID: 35798375 DOI: 10.1136/gutjnl-2022-327737] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cheah JX, Khanna D, Mcmahan ZH. Management of scleroderma gastrointestinal disease: Lights and shadows. Journal of Scleroderma and Related Disorders. [DOI: 10.1177/23971983221086343] [Reference Citation Analysis]
4 Rosen R. Novel Advances in the Evaluation and Treatment of Children With Symptoms of Gastroesophageal Reflux Disease. Front Pediatr 2022;10:849105. [DOI: 10.3389/fped.2022.849105] [Reference Citation Analysis]
5 Mori H, Verbeure W, Schol J, Carbone F, Tack J. Gastrointestinal hormones and regulation of gastric emptying. Curr Opin Endocrinol Diabetes Obes 2022;29:191-9. [PMID: 35081068 DOI: 10.1097/MED.0000000000000707] [Reference Citation Analysis]
6 Guzel T, Mirowska-Guzel D. The Role of Serotonin Neurotransmission in Gastrointestinal Tract and Pharmacotherapy. Molecules 2022;27:1680. [PMID: 35268781 DOI: 10.3390/molecules27051680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Serra J. Management of bloating. Neurogastroenterol Motil 2022;:e14333. [PMID: 35143108 DOI: 10.1111/nmo.14333] [Reference Citation Analysis]
8 Soliman H, Mariano G, Duboc H, Giovinazzo D, Coffin B, Gourcerol G, Moszkowicz D. Gastric motility disorders and their endoscopic and surgical treatments other than bariatric surgery. Journal of Visceral Surgery 2022. [DOI: 10.1016/j.jviscsurg.2022.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Singh R, Zogg H, Ghoshal UC, Ro S. Current Treatment Options and Therapeutic Insights for Gastrointestinal Dysmotility and Functional Gastrointestinal Disorders. Front Pharmacol 2022;13:808195. [DOI: 10.3389/fphar.2022.808195] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Miller J, Khlevner J, Rodriguez L. Upper Gastrointestinal Functional and Motility Disorders in Children. Pediatr Clin North Am 2021;68:1237-53. [PMID: 34736587 DOI: 10.1016/j.pcl.2021.07.009] [Reference Citation Analysis]
11 Cangemi DJ, Lacy BE. Gastroparesis. Curr Opin Gastroenterol 2021;37:596-601. [PMID: 34560721 DOI: 10.1097/MOG.0000000000000782] [Reference Citation Analysis]
12 Lacy BE, Tack J, Gyawali CP. AGA Clinical Practice Update on Management of Medically Refractory Gastroparesis: Expert Review. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01151-4. [PMID: 34757197 DOI: 10.1016/j.cgh.2021.10.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Camilleri M, Sanders KM. Gastroparesis. Gastroenterology 2021:S0016-5085(21)03700-8. [PMID: 34717924 DOI: 10.1053/j.gastro.2021.10.028] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
14 Cangemi DJ, Lacy BE. Gastroparesis and functional dyspepsia: different diseases or different ends of the spectrum? Curr Opin Gastroenterol 2020;36:509-17. [PMID: 32868504 DOI: 10.1097/MOG.0000000000000677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Helson E, Seow CH, Nasser Y. An Unusual Case of Dysphagia. ACG Case Rep J 2021;8:e00661. [PMID: 34621907 DOI: 10.14309/crj.0000000000000661] [Reference Citation Analysis]
16 Camilleri M, Atieh J. New Developments in Prokinetic Therapy for Gastric Motility Disorders. Front Pharmacol 2021;12:711500. [PMID: 34504426 DOI: 10.3389/fphar.2021.711500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
17 Schol J, Wauters L, Dickman R, Drug V, Mulak A, Serra J, Enck P, Tack J; ESNM Gastroparesis Consensus Group. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. Neurogastroenterol Motil 2021;33:e14237. [PMID: 34399024 DOI: 10.1111/nmo.14237] [Reference Citation Analysis]
18 Lacy BE, Cangemi DJ. Controversies in Gastroparesis: Discussing the Sticky Points. Am J Gastroenterol 2021;116:1572-6. [PMID: 33767098 DOI: 10.14309/ajg.0000000000001243] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Wuestenberghs F, Gourcerol G. Editorial: on the road towards treatment of gastroparesis—accelerating but do we get closer? Aliment Pharmacol Ther 2021;54:183-4. [DOI: 10.1111/apt.16375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Hong JT. Current Opinion on Prucalopride in Gastroparesis and Chronic Constipation Treatment: A Focus on Patient Selection and Safety. Ther Clin Risk Manag 2021;17:601-15. [PMID: 34135588 DOI: 10.2147/TCRM.S269330] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Chokshi RV, Chang L. Is It Time to Abandon Gastric Emptying in Patients With Symptoms of Gastroparesis and Functional Dyspepsia? Clin Gastroenterol Hepatol 2021:S1542-3565(21)00569-3. [PMID: 34033924 DOI: 10.1016/j.cgh.2021.05.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Keller J, Hammer HF, Hauser B. 13 C-gastric emptying breath tests: Clinical use in adults and children. Neurogastroenterol Motil 2021;33:e14172. [PMID: 33998745 DOI: 10.1111/nmo.14172] [Reference Citation Analysis]
23 Vasant DH, Lal S. Recent Advances in the Management of Severe Gastrointestinal Dysmotility. Clin Exp Gastroenterol 2021;14:163-72. [PMID: 34007199 DOI: 10.2147/CEG.S249877] [Reference Citation Analysis]
24 Schol J, Wauters L, Dickman R, Drug V, Mulak A, Serra J, Enck P, Tack J; ESNM Gastroparesis Consensus Group. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. United European Gastroenterol J 2021;9:287-306. [PMID: 33939892 DOI: 10.1002/ueg2.12060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
25 Tack J, Schol J, Horowitz M. Gastroparesis: A Dead-end Street After All? Gastroenterology 2021;160:1931-3. [DOI: 10.1053/j.gastro.2021.02.042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
26 Husnik R, Gaschen F. Gastric Motility Disorders in Dogs and Cats. Vet Clin North Am Small Anim Pract 2021;51:43-59. [PMID: 33187622 DOI: 10.1016/j.cvsm.2020.09.002] [Reference Citation Analysis]
27 Ali H, Pamarthy R, Sarfraz S. Role of Prucalopride in Treating Functional Constipation and Gastroparesis: A Systemic Review. Cureus 2021;13:e14306. [PMID: 33968518 DOI: 10.7759/cureus.14306] [Reference Citation Analysis]
28 Bonetto S, Gruden G, Beccuti G, Ferro A, Saracco GM, Pellicano R. Management of Dyspepsia and Gastroparesis in Patients with Diabetes. A Clinical Point of View in the Year 2021. J Clin Med 2021;10:1313. [PMID: 33806716 DOI: 10.3390/jcm10061313] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
29 Murray FR, Schindler V, Hente JM, Fischbach LM, Schnurre L, Deibel A, Hildenbrand FF, Tatu AM, Pohl D. Pyloric dilation with the esophageal functional lumen imaging probe in gastroparesis improves gastric emptying, pyloric distensibility, and symptoms. Gastrointest Endosc 2021;94:486-94. [PMID: 33771556 DOI: 10.1016/j.gie.2021.03.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Gajendran M, Sarosiek I, McCallum R. Metoclopramide nasal spray for management of symptoms of acute and recurrent diabetic gastroparesis in adults. Expert Rev Endocrinol Metab 2021;16:25-35. [PMID: 33739209 DOI: 10.1080/17446651.2021.1886922] [Reference Citation Analysis]
31 Carbone F, De Buysscher R, Van den Houte K, Schol J, Goelen N, Tack J. Relationship Between Gastric Emptying Rate and Simultaneously Assessed Symptoms in Functional Dyspepsia. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00333-5. [PMID: 33746098 DOI: 10.1016/j.cgh.2021.03.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
32 Chedid V, Brandler J, Arndt K, Vijayvargiya P, Wang XJ, Burton D, Harmsen WS, Siegelman J, Chen C, Chen Y, Almansa C, Dukes G, Camilleri M. Randomised study: effects of the 5-HT4 receptor agonist felcisetrag vs placebo on gut transit in patients with gastroparesis. Aliment Pharmacol Ther 2021;53:1010-20. [PMID: 33711180 DOI: 10.1111/apt.16304] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Kaniecki T, Abdi T, McMahan ZH. A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis. Best Pract Res Clin Rheumatol 2021;:101666. [PMID: 33676855 DOI: 10.1016/j.berh.2021.101666] [Reference Citation Analysis]
34 Wei L, Singh R, Ha SE, Martin AM, Jones LA, Jin B, Jorgensen BG, Zogg H, Chervo T, Gottfried-Blackmore A, Nguyen L, Habtezion A, Spencer NJ, Keating DJ, Sanders KM, Ro S. Serotonin Deficiency Is Associated With Delayed Gastric Emptying. Gastroenterology 2021;160:2451-2466.e19. [PMID: 33662386 DOI: 10.1053/j.gastro.2021.02.060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
35 Pannemans J, Masuy I, Tack J. Functional Constipation: Individualising Assessment and Treatment. Drugs 2020;80:947-63. [PMID: 32451924 DOI: 10.1007/s40265-020-01305-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
36 Carbone F, Vanuytsel T, Tack J. The effect of prucalopride on gastric sensorimotor function and satiation in healthy volunteers. Neurogastroenterol Motil 2021;33:e14083. [PMID: 33615630 DOI: 10.1111/nmo.14083] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Lacy BE, Cangemi D, Vazquez-roque M. Management of Chronic Abdominal Distension and Bloating. Clinical Gastroenterology and Hepatology 2021;19:219-231.e1. [DOI: 10.1016/j.cgh.2020.03.056] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
38 Shanker A, Bashashati M, Rezaie A. Gastric Electrical Stimulation for Treatment of Refractory Gastroparesis: the Current Approach to Management. Curr Gastroenterol Rep 2021;23:2. [PMID: 33483775 DOI: 10.1007/s11894-020-00803-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Hardy J, Davis MP. The Management of Nausea and Vomiting Not Related to Anticancer Therapy in Patients with Cancer. Curr Treat Options Oncol 2021;22:17. [PMID: 33443705 DOI: 10.1007/s11864-020-00813-0] [Reference Citation Analysis]
40 Rangan V, Ukleja A. Gastroparesis in the Hospital Setting. Nutr Clin Pract 2021;36:50-66. [PMID: 33336872 DOI: 10.1002/ncp.10611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 McMahan ZH, Khanna D. Managing gastrointestinal complications in patients with systemic sclerosis. Curr Treat Options Gastroenterol 2020;18:531-44. [PMID: 34305387 DOI: 10.1007/s11938-020-00314-x] [Reference Citation Analysis]
42 Ford AC, Mahadeva S, Carbone MF, Lacy BE, Talley NJ. Functional dyspepsia. The Lancet 2020;396:1689-702. [DOI: 10.1016/s0140-6736(20)30469-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 14.5] [Reference Citation Analysis]
43 Sendzischew Shane MA, Moshiree B. Esophageal and Gastric Motility Disorders in the Elderly. Clin Geriatr Med 2021;37:1-16. [PMID: 33213764 DOI: 10.1016/j.cger.2020.08.002] [Reference Citation Analysis]
44 Parkman HP, Sharkey E, McCallum RW, Hasler WL, Koch KL, Sarosiek I, Abell TL, Kuo B, Shulman RJ, Grover M, Farrugia G, Schey R, Tonascia J, Hamilton F, Pasricha PJ; NIH/NIDDK Gastroparesis Consortium. Constipation in Patients With Symptoms of Gastroparesis: Analysis of Symptoms and Gastrointestinal Transit. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31503-2. [PMID: 33130007 DOI: 10.1016/j.cgh.2020.10.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
45 Sullivan A, Temperley L, Ruban A. Pathophysiology, Aetiology and Treatment of Gastroparesis. Dig Dis Sci. 2020;65:1615-1631. [PMID: 32350720 DOI: 10.1007/s10620-020-06287-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
46 Mori H, Schol J, Geeraerts A, Huang IH, Jandee S, Gonlachanvit S, Tseng PH, Lu CL, Kamiya T, Kim N, Lee YY, Kuribayashi S, Tack J, Suzuki H. The Impact of COVID-19 on Gastrointestinal Motility Testing in Asia and Europe. J Clin Med 2020;9:E3189. [PMID: 33019626 DOI: 10.3390/jcm9103189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Camilleri M, Chedid V. Actionable biomarkers: the key to resolving disorders of gastrointestinal function. Gut 2020;69:1730-7. [PMID: 32269066 DOI: 10.1136/gutjnl-2019-320325] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
48 Lee AA, Rao K, Parkman HP, McCallum RW, Sarosiek I, Nguyen LA, Wo JM, Schulman MI, Moshiree B, Rao S, Kuo B, Hasler WL. Baseline Predictors of Longitudinal Changes in Symptom Severity and Quality of Life in Patients With Suspected Gastroparesis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31293-3. [PMID: 32971231 DOI: 10.1016/j.cgh.2020.09.032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
49 Marathe CS, Jones KL, Wu T, Rayner CK, Horowitz M. Gastrointestinal autonomic neuropathy in diabetes. Auton Neurosci 2020;229:102718. [PMID: 32916479 DOI: 10.1016/j.autneu.2020.102718] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
50 Petri M, Singh I, Baker C, Underkofler C, Rasouli N. Diabetic gastroparesis: An overview of pathogenesis, clinical presentation and novel therapies, with a focus on ghrelin receptor agonists. J Diabetes Complications 2021;35:107733. [PMID: 32948398 DOI: 10.1016/j.jdiacomp.2020.107733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Andrews CN, Woo M, Buresi M, Curley M, Gupta M, Tack J, Wilsack L, Nasser Y. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial. Neurogastroenterol Motil 2021;33:e13958. [PMID: 32743954 DOI: 10.1111/nmo.13958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
52 Carlin JL, Lieberman VR, Dahal A, Keefe MS, Xiao C, Birznieks G, Abell TL, Lembo A, Parkman HP, Polymeropoulos MH. Efficacy and Safety of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial. Gastroenterology 2021;160:76-87.e4. [PMID: 32693185 DOI: 10.1053/j.gastro.2020.07.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
53 Mosso E, Bonetto S, Longobardi G, Abenavoli L, Ribaldone DG, Saracco GM, Pellicano R. Management of functional dyspepsia in 2020: a clinical point of view. Minerva Gastroenterol Dietol 2020;66:331-42. [PMID: 32623872 DOI: 10.23736/S1121-421X.20.02732-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
54 Bajaj J, Brenner D, Cai Q, Cash B, Crowell M, Dibaise J, Gallegos-orozco J, Gardner T, Gyawali C, Ha C, Holtmann G, Jamil L, Kaplan G, Karsan H, Kinoshita Y, Lebwohl B, Leontiadis G, Lichtenstein G, Longstreth G, Muthusamy V, Oxentenko A, Pimentel M, Pisegna J, Rubenstein J, Russo M, Saini S, Samadder N, Shaukat A, Simren M, Stevens T, Valdovinos M, Vargas H, Spiegel B, Lacy B. Major Trends in Gastroenterology and Hepatology Between 2010 and 2019: An Overview of Advances From the Past Decade Selected by the Editorial Board of The American Journal of Gastroenterology. Am J Gastroenterol 2020;115:1007-18. [DOI: 10.14309/ajg.0000000000000709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
55 Usai-satta P, Bellini M, Morelli O, Geri F, Lai M, Bassotti G. Gastroparesis: New insights into an old disease. WJG 2020;26:2332-47. [DOI: 10.3748/wjg.v26.i19.2332] [Reference Citation Analysis]
56 Usai-Satta P, Bellini M, Morelli O, Geri F, Lai M, Bassotti G. Gastroparesis: New insights into an old disease. World J Gastroenterol 2020; 26(19): 2333-2348 [PMID: 32476797 DOI: 10.3748/wjg.v26.i19.2333] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
57 Wauters L, Burns G, Ceulemans M, Walker MM, Vanuytsel T, Keely S, Talley NJ. Duodenal inflammation: an emerging target for functional dyspepsia? Expert Opin Ther Targets 2020;24:511-23. [PMID: 32249629 DOI: 10.1080/14728222.2020.1752181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
58 Sharma A, Coles M, Parkman HP. Gastroparesis in the 2020s: New Treatments, New Paradigms. Curr Gastroenterol Rep 2020;22:23. [PMID: 32193707 DOI: 10.1007/s11894-020-00761-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Van den Houte K, Scarpellini E, Verbeure W, Mori H, Schol J, Masuy I, Carbone F, Tack J. The Role of GI Peptides in Functional Dyspepsia and Gastroparesis: A Systematic Review. Front Psychiatry 2020;11:172. [PMID: 32256403 DOI: 10.3389/fpsyt.2020.00172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
60 Malec M, Shega JW. Management of Gastrointestinal Symptoms (Nausea, Anorexia and Cachexia, Constipation) in Advanced Illness. Med Clin North Am 2020;104:439-54. [PMID: 32312408 DOI: 10.1016/j.mcna.2019.12.005] [Reference Citation Analysis]
61 Tack J, Schol J, Van den Houte K, Carbone F. On and Off of Gastric Electrical Stimulation for Refractory Vomiting. Gastroenterology 2020;158:461-3. [DOI: 10.1053/j.gastro.2019.12.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
62 Vandenberghe A, Schol J, Van den Houte K, Masuy I, Carbone F, Tack J. Current and emerging therapeutic options for the management of functional dyspepsia. Expert Opin Pharmacother 2020;21:365-76. [PMID: 31899982 DOI: 10.1080/14656566.2019.1707805] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
63 Kovacic K, Elfar W, Rosen JM, Yacob D, Raynor J, Mostamand S, Punati J, Fortunato JE, Saps M. Update on pediatric gastroparesis: A review of the published literature and recommendations for future research. Neurogastroenterology & Motility 2019;32. [DOI: 10.1111/nmo.13780] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
64 Zhou Z, Wang C, Zheng X, Yu X, Yu C, Zhang D, Xia Y, Chen H, Huang X, Zhang X. Pharmacokinetics, Bioequivalence, and Safety Studies of Prucalopride in Healthy Chinese Subjects. Clin Pharmacol Drug Dev 2020;9:671-6. [PMID: 31797570 DOI: 10.1002/cpdd.754] [Reference Citation Analysis]
65 Grover M, Farrugia G, Stanghellini V. Gastroparesis: a turning point in understanding and treatment. Gut 2019;68:2238-50. [PMID: 31563877 DOI: 10.1136/gutjnl-2019-318712] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 24.0] [Reference Citation Analysis]
66 Carbone F, Van den Houte K, Goelen N, Schol J, Masuy I, Janssen P, Tack J. Mechanism Underlying Symptom Benefit With Prucalopride in Gastroparesis. Am J Gastroenterol 2019;114:1920-1. [DOI: 10.14309/ajg.0000000000000458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
67 Gudsoorkar V, Quigley EMM. Choosing a Prokinetic for Your Patient Beyond Metoclopramide. Am J Gastroenterol 2020;115:5-8. [DOI: 10.14309/ajg.0000000000000463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
68 Tack J, Masuy I, Van Den Houte K, Wauters L, Schol J, Vanuytsel T, Vandenberghe A, Carbone F. Drugs under development for the treatment of functional dyspepsia and related disorders. Expert Opinion on Investigational Drugs 2019;28:871-89. [DOI: 10.1080/13543784.2019.1673365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
69 Daniali M, Nikfar S, Abdollahi M. An overview of the efficacy and safety of prucalopride for the treatment of chronic idiopathic constipation. Expert Opinion on Pharmacotherapy 2019;20:2073-80. [DOI: 10.1080/14656566.2019.1668927] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]